219 related articles for article (PubMed ID: 32038984)
1. Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer.
He C; Huang X; Zhang Y; Cai Z; Lin X; Li S
Front Oncol; 2020; 10():6. PubMed ID: 32038984
[TBL] [Abstract][Full Text] [Related]
2. Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis.
He C; Wang J; Zhang Y; Lin X; Li S
Pancreatology; 2020 Apr; 20(3):477-484. PubMed ID: 32131993
[TBL] [Abstract][Full Text] [Related]
3. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
[TBL] [Abstract][Full Text] [Related]
4. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
5. A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment.
He C; Huang X; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():952. PubMed ID: 32695671
[TBL] [Abstract][Full Text] [Related]
6. Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer.
He C; Sun S; Huang X; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():622318. PubMed ID: 33604301
[TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer.
He C; Sun S; Zhang Y; Li S
J Inflamm Res; 2021; 14():4795-4807. PubMed ID: 34584438
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine plus concurrent irreversible electroporation
Ma YY; Leng Y; Xing YL; Li HM; Chen JB; Niu LZ
World J Clin Cases; 2020 Nov; 8(22):5564-5575. PubMed ID: 33344547
[TBL] [Abstract][Full Text] [Related]
9. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
[No Abstract] [Full Text] [Related]
10. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia.
Yang PC; Huang KW; Pua U; Kim MD; Li SP; Li XY; Liang PC
Eur J Surg Oncol; 2020 May; 46(5):811-817. PubMed ID: 31839436
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival.
Woeste MR; Wilson KD; Kruse EJ; Weiss MJ; Christein JD; White RR; Martin RCG
Front Oncol; 2021; 11():817220. PubMed ID: 35096621
[TBL] [Abstract][Full Text] [Related]
12. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer.
Ma Y; Xing Y; Li H; Yuan T; Liang B; Li R; Li J; Li Z; Li S; Niu L
Front Immunol; 2023; 14():1193040. PubMed ID: 37691923
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
He CB; Wang J; Mao YZ; Lao XM; Li SP
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
[No Abstract] [Full Text] [Related]
14. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC).
Oikonomou D; Karamouzis MV; Moris D; Dimitrokallis N; Papamichael D; Kountourakis P; Astras G; Davakis S; Papalampros A; Schizas D; Petrou AS; Felekouras E
Am J Clin Oncol; 2021 Jul; 44(7):325-330. PubMed ID: 33979098
[TBL] [Abstract][Full Text] [Related]
15. Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study.
Tasu JP; Herpe G; Damion J; Richer JP; Debeane B; Vionnet M; Rouleau L; Carretier M; Ferru A; Ingrand P; Tougeron D
Eur Radiol; 2024 Mar; ():. PubMed ID: 38494526
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
[TBL] [Abstract][Full Text] [Related]
17. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
Marsanic P; Mellano A; Sottile A; De Simone M
Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
[TBL] [Abstract][Full Text] [Related]
19. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery.
Heger U; Mack C; Tjaden C; Pan F; Pausch T; Hinz U; Sommer CM; Hackert T
Pancreatology; 2021 Oct; 21(7):1349-1355. PubMed ID: 34404600
[TBL] [Abstract][Full Text] [Related]
20. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]